Intensive Postpartum Antihypertensive Treatment
Running, not enrolling · Phase 3
Conditions studied: Hypertensive Disorder of Pregnancy
In brief
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Key facts
- Study ID
- NCT05687344
- Run by
- Medical College of Wisconsin
- People needed
- 60
- Starts
- 2023-09-01
- Expected to finish
- 2026-08-30
- Last updated by the study team
- 2026-07-20
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- HDP diagnosis (gestational hypertension or preeclampsia) according to ACOG guidelines
- Postpartum day 0-3 and prior to discharge
- Able to communicate in English or in Spanish
- Age 18 - 45
You may not qualify if…
- Pre-gestational hypertension
- Pre-gestational diabetes ( type 1 or type 2)
- Intent to transfer postpartum to an outside institution of the participating centers
- Known allergy to nifedipine or other significant contraindication to nifedipine
- Inability or unwillingness to provide informed consent
Where it is running
- Froedtert Hospital — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.